An Unusual Etiology of Hypothyroidism and New-Onset Insulin-Dependent Diabetes: A Rare Side Effect of Nivolumab

Nivolumab, a monoclonal antibody targeting programmed cell death 1 receptor, is prescribed for many advanced cancers like malignant melanoma, non-small cell lung cancer, renal cell cancer, etc. With the increase in the use of nivolumab like immunotherapy, the incidences of immune-related side effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Alchalabi, Halah, Albustani, Safa, Fareen, Nusha, Udongwo, Ndausung, Chaughtai, Saira, Holland, Soemiwati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135045/
https://www.ncbi.nlm.nih.gov/pubmed/35651456
http://dx.doi.org/10.7759/cureus.24463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135045/
https://www.ncbi.nlm.nih.gov/pubmed/35651456
http://dx.doi.org/10.7759/cureus.24463

Ejemplares similares